The breakthrough means that men with prostate cancer in the family could be screened to assess their risk, in the same way that women with a family history of breast cancer can be screened for the BRCA1 and BRCA2 genes, which gives them a 50% chance of developing it. The 14 mutations which predict aggressive prostate cancer are in eight genes, which include BRCA1 and BRCA2. The others are ATM, CHEK2, BRIP1, MUTYH, PALB2 and PMS2.
ICYMI, here’s our Healing Story of the Month. Nancy is a #RadicalRemission of Stage 4 ovarian cancer. She combined conventional and alternative treatments to overcome a dire prognosis. Read her full story here: http://www.radicalremission.com/index.php/community/profile/1511-nancy-novack New #RadicalRemission cases are submitted to our site every week! If you know of someone who's had a #RadicalRemission, please encourage them to share their case on our site! www.radicalremission.com/share
Did you know that more than 20,000 women in the United States are diagnosed with ovarian cancer each year, and approximately 15,000 women die annually from the disease. Unfortunately, most cases are diagnosed in their later stages when the prognosis is poor. However, if diagnosed and treated early, when the cancer is confined to the ovary, the five-year survival rate is over 90 percent. #WhyTeal